SFX by Ex Libris Inc.

Title:	Specific Gain- and Loss-of-Function Phenotypes Induced by Satellite-Specific DNA-Binding Drugs Fed to Drosophila melanogaster
Source:	Molecular Cell [1097-2765] Janssen, Sam yr:2000

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Schaufele, F. "Functional sequestration of transcription factor activity by repetitive DNA." The Journal of biological chemistry 282.29 (2007): 20868-76.
description	2.	Asami, Y. "Azaspirene, a fungal product, inhibits angiogenesis by blocking Raf-1 activation." Cancer Science 99.9 (2008): 1853-1858.
description	3.	Johnson, Amber Buescher B. "Hypoxia-induced and stress-specific changes in chromatin structure and function." Mutation research 618.1 (2007): 149-162.
description	4.	Kiessling, A. "Selective Inhibition of c-Myc/Max Dimerization and DNA Binding by Small Molecules." Chemistry & biology 13.7 (2006): 745-51.
description	5.	Lu, J. "Proliferation-dependent and cell cycle regulated transcription of mouse pericentric heterochromatin." The Journal of cell biology 179.3 (2007): 411-21.
description	6.	Coquelle, A. "A New Role for Hypoxia in Tumor Progression." Molecular cell 2.2 (1998): 259-265.
description	7.	Lezhava, T. "Activation of pericentromeric and telomeric heterochromatin in cultured lymphocytes from old individuals." Annals of the New York Academy of Sciences 1100 (2007): 387-99.
description	8.	Janssen, S. "Chromatin opening of DNA satellites by targeted sequence-specific drugs." Molecular cell 6.5 (2000): 999-1011.
description	9.	Yost, H J J. "Regulation of vertebrate left-right asymmetries by extracellular matrix." Nature 357.6374 (1992): 158-161.
description	10.	Al-Mousawi, S. "Enaminones in heterocyclic synthesis: a novel route to tetrahydropyrimidines, dihydropyridines, triacylbenzenes and naphthofurans under microwave irradiation." Molecules 15.1 (2009): 58-67.
description	11.	LYCKEGAARD, E M S. "RIBOSOMAL DNA AND STELLATE GENE COPY NUMBER VARIATION ON THE Y-CHROMOSOME OF DROSOPHILA-MELANOGASTER." Proceedings of the National Academy of Sciences of the United States of America 86.6 (1989): 1944-1948.
description	12.	Onodera, H. "Conformational Significance of EH21A1 A4, Phenolic Derivatives of Geldanamycin, for Hsp90 Inhibitory Activity." Bioorganic & medicinal chemistry letters 18.5: 1588-1591.
description	13.	Eikesdal, Hans Petter P. "Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity." Proceedings of the National Academy of Sciences of the United States of America 105.39 (2008): 15040-5.
description	14.	Li, S. "Functions of histone H2A variants." Animal science journal 77.6 (2006): 549-555.
description	15.	Mitchell, Judith M. "Synthetic studies of pseurotin A: preparation of an advanced lactam aldehyde intermediate." Organic & biomolecular chemistry 3.23 (2005): 4274-4281.
description	16.	Nair, Satish K. "X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA - Molecular Bases of Regulation by Proto-Oncogenic Transcription Factors." Cell 112.2 (2003): 193-205.
description	17.	Prakesch, M. "Chemical biology of apoptosis." Biochemistry and cell biology 86.2 (2008): 203-203.
description	18.	Mo, H. "Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation." Proceedings of the National Academy of Sciences of the United States of America 103.16 (2006): 6344-9.
description	19.	Berg, T. "Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts." Proceedings of the National Academy of Sciences of the United States of America 99.6 (2002): 3830-3835.
description	20.	Dowlati, A. "Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy." Molecular cancer therapeutics 3.4: 459-463.